FluMist is a nasal spray influenza vaccine manufactured by MedImmune, Inc. that was first introduced in 2003. It is live virus vaccine that has flu viruses that have been attenuated (weakened). It is also called live attenuated influenza vaccine (LAIV).   October 2019 – 50 Years Ago in The Journal of Pediatrics February 2019 – Live

Fluarix is a flu shot created by GSK. Fluarix Quadrivalent Package Insert Fluarix Quadrivalent Supporting Documents September 27, 2018 – 2018-2019 Recommendations for influenza prevention and treatment in children : an update for pediatric providers ” 2018 – Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind,

FLUAD® Seqirus Inc. US Package Insert September 4, 2019 – Flu Vaccine With Adjuvant – Flu Vaccine with Adjuvant, brand name FLUAD “FLUAD is a standard-dose, three-component (trivalent) inactivated flu vaccine, manufactured by Seqirus that contains an adjuvant. FLUAD is designed specifically for people 65 years and older. It is

  Flublok [Influenza Vaccine] is a sterile, clear, colorless solution of recombinant hemagglutinin (HA) proteins from three influenza viruses for intramuscular injection. It contains purified HA proteins produced in a continuous insect cell line that is derived from cells of the fall army worm,  Spodoptera frugiperda, and grown in serum-free medium composed of chemically-defined lipids,

Afluria is a flu vaccine primarily used in Australia.  (CSL/Merck – Australia) Afluria Quad Vaccine Package Insert Afluria Quad Documents April 1, 2019 – Influenza: overview on prevention and therapy (full text) “Healthy children 6–59 months of age were enrolled. Children were excluded if they were febrile (axillary temperature ≥ 99.5 °F [≥37.5 °C]), acutely ill, immunocompromised,

  STN: BL 125546 Proper Name: Meningococcal Group B Vaccine Trade Name: BEXSERO Manufacture: Novartis Vaccines and Diagnostics, Inc Indication: Active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age. Product Information Package Insert – BEXSERO Supporting Documents May 31, 2018 Approval Letter – BEXSERO October

  August 28, 2018 – Emerging clinical experience with vaccines against group B meningococcal disease “While recent data from the United Kingdom supports the potential for protein-based vaccines to provide direct protection against MenB disease in immunised children, further research is required to understand the breadth and duration of this protection. A more detailed

The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine surveillance program co-sponsored by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). VAERS is a post-marketing safety surveillance program that collects information about adverse events that occur after the administration of vaccines

Third leading cause of death in newborns CDC Wonder The table above is coming right from a CDC website. Even if the CDC claims there are other reasons for SIDS (Sudden Infant Death Syndrome) or SUIDS (Sudden Unexpected Infant Death Syndrome) the following VAERS search, CDC articles, and journal articles

Meningitis is inflammation of the meninges, the lining which surrounds the brain. The disease should not be confused with encephalitis which is inflammation of the brain itself. Essentially, there are two distinct types of meningitis; aseptic (usually caused by viral infections) and bacterial. Bacterial meningitis, while it is comparatively rare, is